Jonathan Wickel

Jena, TH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Kappa Free Light Chain for Diagnosis and Neurofilament Light Chain for Prognosis in Autoimmune Encephalitis.

Kappa Free Light Chain for Diagnosis and Neurofilament Light Chain for Prognosis in Autoimmune Encephalitis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 03, 2026

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Journal: Neurology

Published: July 02, 2026

Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 Pandemic.

Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 Pandemic.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 13, 2026

Therapeutic effect of T-cell engager in two patients with autoimmune neuropathy.

Therapeutic effect of T-cell engager in two patients with autoimmune neuropathy.

Journal: Nature communications

Published: October 30, 2025

Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease.

Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease.

Journal: JAMA neurology

Published: August 04, 2025

Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort Study.

Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 07, 2025

Chimeric antigen receptor T-cell therapy for stiff-person syndrome: bridging innovation and clinical challenges in neuroimmunology.

Chimeric antigen receptor T-cell therapy for stiff-person syndrome: bridging innovation and clinical challenges in neuroimmunology.

Journal: Therapeutic advances in neurological disorders

Published: April 01, 2025

The Clinical Trial Landscape in Autoimmune Encephalitis: Challenges and Opportunities.

The Clinical Trial Landscape in Autoimmune Encephalitis: Challenges and Opportunities.

Journal: Neurology

Published: March 27, 2025

Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2.

Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2.

Journal: Journal of neurology

Published: December 09, 2024

Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.

Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.

Journal: Neurology

Published: October 01, 2024

Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis.

Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis.

Journal: Frontiers in immunology

Published: September 24, 2024

Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitis.

Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitis.

Journal: Med (New York, N.Y.)

Published: September 13, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026